Mark Worthington
General Counsel at Athira Pharma, Inc. (LONA); General Counsel at LeonaBio, Inc. (LONA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $13K